Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference

Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined an...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 55; no. 12; pp. 1849 - 1856
Main Authors Panteghini, Mauro, Ceriotti, Ferruccio, Jones, Graham, Oosterhuis, Wytze, Plebani, Mario, Sandberg, Sverre
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 26.10.2017
Walter De Gruyter & Company
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be “fit for purpose” and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups.
AbstractList Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be “fit for purpose” and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups.
Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be "fit for purpose" and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups.Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be "fit for purpose" and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups.
Author Ceriotti, Ferruccio
Panteghini, Mauro
Plebani, Mario
Jones, Graham
Sandberg, Sverre
Oosterhuis, Wytze
AuthorAffiliation .
AuthorAffiliation_xml – name: .
Author_xml – sequence: 1
  givenname: Mauro
  surname: Panteghini
  fullname: Panteghini, Mauro
  email: mauro.panteghini@unimi.it
  organization: Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy, Phone: +39 02 3904 2806, Fax: +39 02 50319835
– sequence: 2
  givenname: Ferruccio
  surname: Ceriotti
  fullname: Ceriotti, Ferruccio
  organization: Central Laboratory, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy
– sequence: 3
  givenname: Graham
  surname: Jones
  fullname: Jones, Graham
  organization: SydPath, St Vincent’s Hospital, Sydney, NSW, Australia
– sequence: 4
  givenname: Wytze
  surname: Oosterhuis
  fullname: Oosterhuis, Wytze
  organization: Department of Clinical Chemistry and Haematology, Zuyderland Medical Center, Heerlen, The Netherlands
– sequence: 5
  givenname: Mario
  surname: Plebani
  fullname: Plebani, Mario
  organization: Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy
– sequence: 6
  givenname: Sverre
  surname: Sandberg
  fullname: Sandberg, Sverre
  organization: Norwegian Porphyria Centre, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29031018$$D View this record in MEDLINE/PubMed
BookMark eNp1kcuLFDEQh4OsuA-9epSAFy-9pjqvaQ_CMviCFQ_qOWSSypqlOxmTbmX-ezM7OyCLXpIcvq9SVb9zcpJyQkKeA7sECfK1c-PU9Qx0x7TuH5EzEFx3gnM4uXuLTqkeTsl5rbeMgZRCPyGn_cA4MFidkV9f52JnvIlY6ZypxxAT0i2WkMtkk0Nat-hiiM7OMadKY6Kj3eQm5bKjE_romvGGcrpDWyrNiYaSJzr_QPo5jjbR4w-OrnMKWLBVfUoeBztWfHZ_X5Dv7999W3_srr98-LS-uu6cUGruwgCbsOIWmB9A98xxYZUGrnjPRAgDb0ebPWj0lgUllPcbHrxfSSWt95ZfkFeHutuSfy5YZzPF6nBsfWFeqoFBggDRc9bQlw_Q27yU1LprlJJCDlqrRr24p5ZNG95sS5xs2ZnjRhsgDoArudaCwbg43-2urSGOBpjZB2f2wZl9cGYfXNMuH2jHyv8V3h6E33acsXi8KcuuPf7q-p-ilNDDSgz8D9AQr4s
CitedBy_id crossref_primary_10_1515_cclm_2023_0069
crossref_primary_10_1515_cclm_2023_0740
crossref_primary_10_17116_labs2022110315
crossref_primary_10_1515_cclm_2018_0603
crossref_primary_10_1515_cclm_2023_0027
crossref_primary_10_1515_cclm_2023_1314
crossref_primary_10_1016_j_jtemb_2019_126414
crossref_primary_10_1515_cclm_2021_0170
crossref_primary_10_1515_cclm_2023_1439
crossref_primary_10_1515_cclm_2019_0253
crossref_primary_10_1515_cclm_2024_0787
crossref_primary_10_1016_j_jmsacl_2023_01_002
crossref_primary_10_1515_cclm_2018_0098
crossref_primary_10_1515_cclm_2019_1336
crossref_primary_10_1515_almed_2022_0036
crossref_primary_10_1515_cclm_2020_0371
crossref_primary_10_1515_cclm_2022_0605
crossref_primary_10_1515_cclm_2022_0128
crossref_primary_10_1016_j_cca_2020_10_010
crossref_primary_10_1016_j_cca_2021_08_013
crossref_primary_10_1373_clinchem_2018_300954
crossref_primary_10_1515_cclm_2020_0017
crossref_primary_10_1515_cclm_2022_1257
crossref_primary_10_1016_j_PLABM_2018_e00097
crossref_primary_10_1515_almed_2023_0057
crossref_primary_10_1515_cclm_2024_1203
crossref_primary_10_1515_cclm_2024_0551
crossref_primary_10_1515_cclm_2019_1128
crossref_primary_10_1080_10408363_2024_2434562
crossref_primary_10_1515_cclm_2018_0343
crossref_primary_10_1515_cclm_2022_0806
crossref_primary_10_1515_cclm_2023_0045
crossref_primary_10_1515_cclm_2023_1257
crossref_primary_10_1515_almed_2019_0016
crossref_primary_10_1515_cclm_2022_0755
crossref_primary_10_1515_almed_2021_0097
crossref_primary_10_1515_cclm_2023_0965
crossref_primary_10_1515_cclm_2022_0032
crossref_primary_10_1515_cclm_2024_0168
crossref_primary_10_1515_labmed_2023_0098
crossref_primary_10_1002_jcla_23581
crossref_primary_10_11613_BM_2018_020502
crossref_primary_10_1016_j_clinbiochem_2018_03_007
crossref_primary_10_1515_almed_2020_0008
crossref_primary_10_1016_j_clinbiochem_2018_02_018
crossref_primary_10_1515_cclm_2023_1286
crossref_primary_10_1016_j_clinbiochem_2021_05_003
crossref_primary_10_1016_j_jtha_2023_12_013
crossref_primary_10_1515_almed_2023_0155
crossref_primary_10_1016_j_plabm_2020_e00199
crossref_primary_10_1016_j_cca_2024_120107
crossref_primary_10_1016_j_cca_2020_06_021
crossref_primary_10_37871_jbres1369
crossref_primary_10_1177_00045632241311453
crossref_primary_10_1016_j_cca_2023_117233
crossref_primary_10_1016_j_cca_2021_11_001
crossref_primary_10_1515_cclm_2019_0658
crossref_primary_10_1515_cclm_2018_1212
crossref_primary_10_1093_clinchem_hvab178
Cites_doi 10.1515/CCLM.2010.020
10.1373/clinchem.2011.165308
10.1016/j.cca.2015.08.007
10.3109/10408363.2016.1150252
10.1373/clinchem.2016.258962
10.1016/j.cca.2013.11.022
10.1373/clinchem.2016.265058
10.1016/j.clinbiochem.2017.02.002
10.1016/j.clinbiochem.2017.03.009
10.1373/clinchem.2011.162719
10.1373/clinchem.2017.275115
10.1373/clinchem.2016.269811
10.1080/00365519950185175
10.1016/j.atherosclerosis.2012.03.035
10.1515/cclm-2015-0897
10.1007/s00769-009-0630-8
10.1016/j.atherosclerosis.2013.12.016
10.1515/CCLM.2010.140
10.1515/cclm-2016-0220
10.1373/clinchem.2011.168641
10.1177/000456329102800313
10.1080/003655101300133630
10.1515/cclm.2011.791
10.1016/j.cca.2014.04.002
10.1515/cclm-2016-0035
ContentType Journal Article
Copyright Copyright Walter De Gruyter & Company 2017
Copyright_xml – notice: Copyright Walter De Gruyter & Company 2017
CorporateAuthor Task Force on Performance Specifications in Laboratory Medicine of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
CorporateAuthor_xml – name: Task Force on Performance Specifications in Laboratory Medicine of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1515/cclm-2017-0772
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biotechnology Research Abstracts
Technology Research Database
Toxicology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Biotechnology Research Abstracts
MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
EndPage 1856
ExternalDocumentID 29031018
10_1515_cclm_2017_0772
10_1515_cclm_2017_077255121849
Genre Journal Article
GroupedDBID ---
0R~
0~D
29B
354
36B
4.4
53G
5GY
5RE
AAAEU
AABBZ
AAFPC
AAGVJ
AAILP
AALGR
AAONY
AAOQK
AAOWA
AAPJK
AAQCX
AARRE
AASQH
AAWFC
AAXCG
ABAOT
ABAQN
ABDRH
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABRDF
ABRQL
ABUVI
ABWLS
ABXMZ
ABYBW
ACDEB
ACEFL
ACGFS
ACIWK
ACMKP
ACPMA
ACPRK
ACUND
ACXLN
ACYCL
ACZBO
ADDWE
ADEQT
ADGQD
ADGYE
ADOZN
AECWL
AEDGQ
AEGVQ
AEICA
AEJTT
AEKEB
AENEX
AEQDQ
AERZL
AEXIE
AFBAA
AFBDD
AFBQV
AFCXV
AFGDO
AFGNR
AFQUK
AFRAH
AFYRI
AGBEV
AHOVO
AHVWV
AHXUK
AIERV
AIKXB
AIWOI
AJATJ
AJHHK
AKXKS
ALMA_UNASSIGNED_HOLDINGS
ALUKF
ALYBR
AMAVY
ASYPN
AZMOX
BAKPI
BBCWN
BCIFA
BWHEM
CGQUA
CS3
DU5
EBS
EJD
EMOBN
F5P
FSTRU
HZ~
IY9
KDIRW
N9A
O9-
OBC
OBS
OEB
OES
OHH
OVD
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
AAYXX
CITATION
ABVMU
CGR
CUY
CVF
DBYYV
ECM
EIF
NPM
7QO
7T7
7TK
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c466t-f91bf83a10d91720c34a671363204ff934ff017f7eda0f646ddb3fdd8565adda3
ISSN 1434-6621
1437-4331
IngestDate Fri Jul 11 11:09:36 EDT 2025
Sun Jun 29 16:39:03 EDT 2025
Wed Feb 19 02:42:13 EST 2025
Tue Jul 01 02:49:29 EDT 2025
Thu Apr 24 23:04:51 EDT 2025
Thu Jul 10 10:38:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords biological variation
outcome
performance specifications
Language English
License This content is free.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c466t-f91bf83a10d91720c34a671363204ff934ff017f7eda0f646ddb3fdd8565adda3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.degruyter.com/document/doi/10.1515/cclm-2017-0772/pdf
PMID 29031018
PQID 1965459776
PQPubID 105421
PageCount 8
ParticipantIDs proquest_miscellaneous_1951414230
proquest_journals_1965459776
pubmed_primary_29031018
crossref_citationtrail_10_1515_cclm_2017_0772
crossref_primary_10_1515_cclm_2017_0772
walterdegruyter_journals_10_1515_cclm_2017_077255121849
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-26
PublicationDateYYYYMMDD 2017-10-26
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-26
  day: 26
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Berlin
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2017
Publisher De Gruyter
Walter De Gruyter & Company
Publisher_xml – name: De Gruyter
– name: Walter De Gruyter & Company
References (ref731) 2011; 57
(ref21) 2014; 432
(ref61) 2015; 53
(ref111) 2016; 53
(ref641) 2016; 53
(ref141) 2016; 62
(ref1021) 2017; 63
(ref31) 2015; 53
(ref591) 2015; 53
(ref151) 2017; 55
(ref541) 2012; 50
(ref1041) 2017; 55
(ref561) 2015; 53
(ref391) 2015; 53
(ref831) 1991; 28
(ref101) 2015; 53
(ref131) 2013; 51
(ref161) 2017; 55
(ref91) 2015; 53
(ref571) 1999; 59
(ref361) 2017; 50
(ref231) 2017; 55
(ref551) 2014; 432
(ref721) 2010; 48
(ref601) 2015; 53
(ref941) 2012; 222
(ref281) 2017
(ref711) 2014; 432
(ref1011) 2016; 54
(ref801) 2015; 450
(ref121) 2015; 53
(ref481) 2016; 54
(ref751) 2015; 53
(ref651) 2015; 53
(ref221) 2015; 53
(ref621) 2015; 53
(ref511) 2017; 55
(ref291) 2011; 57
(ref921) 2015; 53
(ref881) 2016; 54
(ref671) 2016; 62
(ref311) 2017; 55
(ref741) 2013; 51
(ref41) 1999; 59
(ref661) 2013; 51
(ref321) 2006; 44
(ref501) 2017; 63
(ref791) 2016; 54
(ref631) 2015; 53
(ref961) 2002; 39
(ref341) 2015; 53
(ref871) 2015; 53
(ref401) 2014; 233
(ref581) 2010; 15
(ref971) 2017; 63
(ref531) 2010; 48
(ref411) 2012; 222
(ref191) 2010; 48
(ref471) 2017; 55
(ref1001) 2017; 55
(ref211) 2013; 51
(ref981) 2001; 61
(ref781) 2011; 57
(ref771) 2017; 55
(ref241) 2017; 55
(ref451) 2001; 61
(ref331) 2014; 52
(ref841) 2017; 55
(ref71) 2015; 53
(ref861) 2014; 52
(ref271) 2015; 450
(ref251) 2011; 57
(ref381) 2016; 54
(ref1031) 2017; 63
(ref261) 2016; 54
(ref181) 2014; 432
(ref851) 2006; 44
(ref51) 2010; 15
(ref01) 2010; 48
(ref431) 2002; 39
(ref821) 2011; 57
(ref441) 2017; 63
(ref461) 2017; 50
(ref891) 2017; 50
(ref81) 2016; 54
(ref991) 2017; 50
(ref11) 2012; 50
(ref761) 2017; 55
(ref811) 2017
(ref931) 2014; 233
(ref301) 1991; 28
(ref351) 2016; 54
(ref911) 2016; 54
(ref611) 2016; 54
(ref491) 2017; 63
(ref681) 2017; 55
(ref201) 2011; 57
(ref691) 2017; 55
References_xml – volume: 48
  start-page: 7
  year: 2010
  ident: ref01
  article-title: Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
  publication-title: Clin Chem Lab Med
  doi: 10.1515/CCLM.2010.020
– volume: 57
  start-page: 1334
  year: 2011
  ident: ref821
  article-title: Gross overestimation of total allowable error based on biological variation
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.165308
– volume: 450
  start-page: 125
  year: 2015
  ident: ref801
  article-title: The calibrator value assignment protocol of the Abbott enzymatic creatinine assay is inadequate for ensuring suitable quality of serum measurements
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2015.08.007
– volume: 51
  start-page: 973
  year: 2013
  ident: ref661
  article-title: Defining acceptable limits for the metrological traceability of specific measurands
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: S146
  year: 2017
  ident: ref471
  article-title: Impact of measurement error of plasma glucose on clinical classification: a simulation analysis
  publication-title: Clin Chem Lab Med
– volume: 39
  start-page: 213
  year: 2002
  ident: ref961
  article-title: Decision limit for troponin I and assay performance
  publication-title: Ann Clin Biochem
– volume: 54
  start-page: 223
  year: 2016
  ident: ref261
  article-title: Useful measures and models for analytical quality management in medical laboratories
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 313
  year: 2016
  ident: ref641
  article-title: Generation of data on within-subject biological variation in laboratory medicine: an update
  publication-title: Crit Rev Clin Lab Sci
  doi: 10.3109/10408363.2016.1150252
– volume: 51
  start-page: 1719
  year: 2013
  ident: ref741
  article-title: Standardization and analytical goals for glycated hemoglobin measurement
  publication-title: Clin Chem Lab Med
– volume: 52
  start-page: 951
  year: 2014
  ident: ref861
  article-title: Harmonization of quality indicators in laboratory medicine. A preliminary consensus
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: S1068
  year: 2017
  ident: ref311
  article-title: Estimates of within-subject biological variation for total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and apolipoproteins A1, B based on review of published papers using a critical appraisal check list – Results from the EFLM TFG-BVD
  publication-title: Clin Chem Lab Med
– volume: 62
  start-page: 1255
  year: 2016
  ident: ref671
  article-title: Analytical bias exceeding desirable quality goal in 4 out of 5 common immunoassays: results of a native single serum sample external quality assessment program for cobalamin, folate, ferritin, thyroid-stimulating hormone, and free T4 analyses
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.258962
– volume: 432
  start-page: 55
  year: 2014
  ident: ref551
  article-title: Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2013.11.022
– volume: 53
  start-page: 841
  year: 2015
  ident: ref391
  article-title: Setting analytical performance specifications based on outcome studies – is it possible?
  publication-title: Clin Chem Lab Med
– volume: 63
  start-page: 585
  year: 2017
  ident: ref441
  article-title: Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to assay bias and imprecision
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.265058
– volume: 55
  start-page: e47
  year: 2017
  ident: ref681
  article-title: Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: S170
  year: 2017
  ident: ref1041
  article-title: Biological variation estimates obtained from 91 healthy subjects for six electrolytes in serum. EBIOVAR study of the EFLM Working-Group on Biological Variation
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 905
  year: 2015
  ident: ref121
  article-title: Performance criteria for combined uncertainty budget in the implementation of metrological traceability
  publication-title: Clin Chem Lab Med
– volume: 50
  start-page: 550
  year: 2017
  ident: ref361
  article-title: Performance specifications for the extra-analytical phases of laboratory testing: Why and how
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2017.02.002
– volume: 50
  start-page: 587
  year: 2017
  ident: ref461
  article-title: Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2017.03.009
– volume: 57
  start-page: 1204
  year: 2011
  ident: ref201
  article-title: The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.162719
– volume: 53
  start-page: 871
  year: 2015
  ident: ref621
  article-title: Reliability of biological variation data available in an online database: need for improvement
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 919
  year: 2015
  ident: ref221
  article-title: Analytical performance specifications for EQA schemes – need for harmonisation
  publication-title: Clin Chem Lab Med
– volume: 63
  start-page: 1527
  year: 2017
  ident: ref501
  article-title: The EuBIVAS Project: Within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2017.275115
– volume: 54
  start-page: 523
  year: 2016
  ident: ref911
  article-title: Laboratory medicine in the new healthcare environment
  publication-title: Clin Chem Lab Med
– volume: 63
  start-page: 1141
  year: 2017
  ident: ref1021
  article-title: Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.269811
– volume: 59
  start-page: 475
  year: 1999
  ident: ref571
  article-title: The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25–26 April 1999
  publication-title: Scand J Clin Lab Invest
  doi: 10.1080/00365519950185175
– volume: 63
  start-page: 1141
  year: 2017
  ident: ref491
  article-title: Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.269811
– volume: 53
  start-page: 919
  year: 2015
  ident: ref751
  article-title: Analytical performance specifications for EQA schemes – need for harmonisation
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 829
  year: 2015
  ident: ref591
  article-title: Defining analytical performance specifications 15 years after the Stockholm conference
  publication-title: Clin Chem Lab Med
– volume: 222
  start-page: 564
  year: 2012
  ident: ref941
  article-title: A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE
  publication-title: Atheroscler
  doi: 10.1016/j.atherosclerosis.2012.03.035
– volume: 44
  start-page: 750
  year: 2006
  ident: ref321
  article-title: Errors in clinical laboratories or errors in laboratory medicine?
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 837
  year: 2015
  ident: ref31
  article-title: The 1999 Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine
  publication-title: Clin Chem Lab Med
– volume: 54
  start-page: 1169
  year: 2016
  ident: ref881
  article-title: Performance criteria and quality indicators for the post-analytical phase
  publication-title: Clin Chem Lab
  doi: 10.1515/cclm-2015-0897
– volume: 15
  start-page: 323
  year: 2010
  ident: ref51
  article-title: Strategies to set global analytical quality specifications in laboratory medicine: 10 years on from the Stockholm Consensus Conference
  publication-title: Accred Qual Assur
  doi: 10.1007/s00769-009-0630-8
– volume: 233
  start-page: 83
  year: 2014
  ident: ref931
  article-title: Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
  publication-title: Atheroscler
  doi: 10.1016/j.atherosclerosis.2013.12.016
– volume: 55
  start-page: S146
  year: 2017
  ident: ref1001
  article-title: Impact of measurement error of plasma glucose on clinical classification: a simulation analysis
  publication-title: Clin Chem Lab Med
– volume: 432
  start-page: 55
  year: 2014
  ident: ref21
  article-title: Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2013.11.022
– volume: 48
  start-page: 623
  year: 2010
  ident: ref191
  article-title: Recommendations for the implementation of international standardization of glycated hemoglobin in Italy
  publication-title: Clin Chem Lab Med
  doi: 10.1515/CCLM.2010.140
– volume: 53
  start-page: 879
  year: 2015
  ident: ref101
  article-title: A checklist for critical appraisal of studies of biological variation
  publication-title: Clin Chem Lab Med
– volume: 54
  start-page: 223
  year: 2016
  ident: ref791
  article-title: Useful measures and models for analytical quality management in medical laboratories
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: e47
  year: 2017
  ident: ref151
  article-title: Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
  publication-title: Clin Chem Lab Med
– volume: 450
  start-page: 125
  year: 2015
  ident: ref271
  article-title: The calibrator value assignment protocol of the Abbott enzymatic creatinine assay is inadequate for ensuring suitable quality of serum measurements
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2015.08.007
– volume: 53
  start-page: 837
  year: 2015
  ident: ref561
  article-title: The 1999 Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: 334
  year: 2017
  ident: ref771
  article-title: Progress and impact of enzyme measurement standardization
  publication-title: Clin Chem Lab Med
– volume: 63
  start-page: 1527
  year: 2017
  ident: ref1031
  article-title: The EuBIVAS Project: Within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2017.275115
– volume: 55
  start-page: 203
  year: 2017
  ident: ref691
  article-title: Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2016-0220
– volume: 52
  start-page: 951
  year: 2014
  ident: ref331
  article-title: Harmonization of quality indicators in laboratory medicine. A preliminary consensus
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 829
  year: 2015
  ident: ref61
  article-title: Defining analytical performance specifications 15 years after the Stockholm conference
  publication-title: Clin Chem Lab Med
– volume: 48
  start-page: 7
  year: 2010
  ident: ref531
  article-title: Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
  publication-title: Clin Chem Lab Med
  doi: 10.1515/CCLM.2010.020
– volume: 57
  start-page: 1670
  year: 2011
  ident: ref251
  article-title: Proficiency testing/external quality assessment: current challenges and future directions
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.168641
– volume: 55
  start-page: 949
  year: 2017
  ident: ref761
  article-title: Analytical performance specifications for external quality assessment – definitions and descriptions
  publication-title: Clin Chem Lab Med
– volume: 28
  start-page: 272
  year: 1991
  ident: ref301
  article-title: A comparison of analytical goals for haemoglobin A1c assays derived using different strategies
  publication-title: Ann Clin Biochem
  doi: 10.1177/000456329102800313
– volume: 50
  start-page: 550
  year: 2017
  ident: ref891
  article-title: Performance specifications for the extra-analytical phases of laboratory testing: Why and how
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2017.02.002
– volume: 54
  start-page: 1169
  year: 2016
  ident: ref351
  article-title: Performance criteria and quality indicators for the post-analytical phase
  publication-title: Clin Chem Lab
  doi: 10.1515/cclm-2015-0897
– volume: 61
  start-page: 191
  year: 2001
  ident: ref451
  article-title: Evaluation of systematic and random factors in measurements of FPG as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus
  publication-title: Scand J Clin Lab Invest
  doi: 10.1080/003655101300133630
– volume: 54
  start-page: 523
  year: 2016
  ident: ref381
  article-title: Laboratory medicine in the new healthcare environment
  publication-title: Clin Chem Lab Med
– volume: 15
  start-page: 323
  year: 2010
  ident: ref581
  article-title: Strategies to set global analytical quality specifications in laboratory medicine: 10 years on from the Stockholm Consensus Conference
  publication-title: Accred Qual Assur
  doi: 10.1007/s00769-009-0630-8
– volume: 55
  start-page: S1068
  year: 2017
  ident: ref841
  article-title: Estimates of within-subject biological variation for total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and apolipoproteins A1, B based on review of published papers using a critical appraisal check list – Results from the EFLM TFG-BVD
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 313
  year: 2016
  ident: ref111
  article-title: Generation of data on within-subject biological variation in laboratory medicine: an update
  publication-title: Crit Rev Clin Lab Sci
  doi: 10.3109/10408363.2016.1150252
– volume: 57
  start-page: 1670
  year: 2011
  ident: ref781
  article-title: Proficiency testing/external quality assessment: current challenges and future directions
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.168641
– volume: 59
  start-page: 475
  year: 1999
  ident: ref41
  article-title: The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25–26 April 1999
  publication-title: Scand J Clin Lab Invest
  doi: 10.1080/00365519950185175
– year: 2017
  ident: ref281
  article-title: The use of error and uncertainty methods in the medical laboratory
  publication-title: Clin Chem Lab Med
– volume: 57
  start-page: 1334
  year: 2011
  ident: ref291
  article-title: Gross overestimation of total allowable error based on biological variation
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.165308
– volume: 28
  start-page: 272
  year: 1991
  ident: ref831
  article-title: A comparison of analytical goals for haemoglobin A1c assays derived using different strategies
  publication-title: Ann Clin Biochem
  doi: 10.1177/000456329102800313
– volume: 51
  start-page: 1719
  year: 2013
  ident: ref211
  article-title: Standardization and analytical goals for glycated hemoglobin measurement
  publication-title: Clin Chem Lab Med
– volume: 233
  start-page: 83
  year: 2014
  ident: ref401
  article-title: Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
  publication-title: Atheroscler
  doi: 10.1016/j.atherosclerosis.2013.12.016
– year: 2017
  ident: ref811
  article-title: The use of error and uncertainty methods in the medical laboratory
  publication-title: Clin Chem Lab Med
– volume: 51
  start-page: 973
  year: 2013
  ident: ref131
  article-title: Defining acceptable limits for the metrological traceability of specific measurands
  publication-title: Clin Chem Lab Med
– volume: 44
  start-page: 750
  year: 2006
  ident: ref851
  article-title: Errors in clinical laboratories or errors in laboratory medicine?
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: 334
  year: 2017
  ident: ref241
  article-title: Progress and impact of enzyme measurement standardization
  publication-title: Clin Chem Lab Med
– volume: 50
  start-page: 1237
  year: 2012
  ident: ref11
  article-title: Implementation of standardization in clinical practice: not always an easy task
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm.2011.791
– volume: 39
  start-page: 213
  year: 2002
  ident: ref431
  article-title: Decision limit for troponin I and assay performance
  publication-title: Ann Clin Biochem
– volume: 53
  start-page: 833
  year: 2015
  ident: ref601
  article-title: Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 841
  year: 2015
  ident: ref921
  article-title: Setting analytical performance specifications based on outcome studies – is it possible?
  publication-title: Clin Chem Lab Med
– volume: 432
  start-page: 127
  year: 2014
  ident: ref181
  article-title: Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2014.04.002
– volume: 48
  start-page: 623
  year: 2010
  ident: ref721
  article-title: Recommendations for the implementation of international standardization of glycated hemoglobin in Italy
  publication-title: Clin Chem Lab Med
  doi: 10.1515/CCLM.2010.140
– volume: 54
  start-page: 195
  year: 2016
  ident: ref81
  article-title: Total error vs. measurement uncertainty: the match continues
  publication-title: Clin Chem Lab Med
– volume: 432
  start-page: 127
  year: 2014
  ident: ref711
  article-title: Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2014.04.002
– volume: 55
  start-page: 203
  year: 2017
  ident: ref161
  article-title: Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2016-0220
– volume: 50
  start-page: 587
  year: 2017
  ident: ref991
  article-title: Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results
  publication-title: Clin Biochem
  doi: 10.1016/j.clinbiochem.2017.03.009
– volume: 54
  start-page: 195
  year: 2016
  ident: ref611
  article-title: Total error vs. measurement uncertainty: the match continues
  publication-title: Clin Chem Lab Med
– volume: 55
  start-page: 949
  year: 2017
  ident: ref231
  article-title: Analytical performance specifications for external quality assessment – definitions and descriptions
  publication-title: Clin Chem Lab Med
– volume: 54
  start-page: 1599
  year: 2016
  ident: ref1011
  article-title: Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2016-0035
– volume: 55
  start-page: S170
  year: 2017
  ident: ref511
  article-title: Biological variation estimates obtained from 91 healthy subjects for six electrolytes in serum. EBIOVAR study of the EFLM Working-Group on Biological Variation
  publication-title: Clin Chem Lab Med
– volume: 54
  start-page: 1599
  year: 2016
  ident: ref481
  article-title: Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2016-0035
– volume: 222
  start-page: 564
  year: 2012
  ident: ref411
  article-title: A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE
  publication-title: Atheroscler
  doi: 10.1016/j.atherosclerosis.2012.03.035
– volume: 53
  start-page: 943
  year: 2015
  ident: ref871
  article-title: Performance criteria and quality indicators for the pre-analytical phase
  publication-title: Clin Chem Lab Med
– volume: 61
  start-page: 191
  year: 2001
  ident: ref981
  article-title: Evaluation of systematic and random factors in measurements of FPG as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus
  publication-title: Scand J Clin Lab Invest
  doi: 10.1080/003655101300133630
– volume: 53
  start-page: 905
  year: 2015
  ident: ref651
  article-title: Performance criteria for combined uncertainty budget in the implementation of metrological traceability
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 943
  year: 2015
  ident: ref341
  article-title: Performance criteria and quality indicators for the pre-analytical phase
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 833
  year: 2015
  ident: ref71
  article-title: Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine
  publication-title: Clin Chem Lab Med
– volume: 53
  start-page: 871
  year: 2015
  ident: ref91
  article-title: Reliability of biological variation data available in an online database: need for improvement
  publication-title: Clin Chem Lab Med
– volume: 63
  start-page: 585
  year: 2017
  ident: ref971
  article-title: Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to assay bias and imprecision
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.265058
– volume: 50
  start-page: 1237
  year: 2012
  ident: ref541
  article-title: Implementation of standardization in clinical practice: not always an easy task
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm.2011.791
– volume: 53
  start-page: 879
  year: 2015
  ident: ref631
  article-title: A checklist for critical appraisal of studies of biological variation
  publication-title: Clin Chem Lab Med
– volume: 57
  start-page: 1204
  year: 2011
  ident: ref731
  article-title: The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.162719
– volume: 62
  start-page: 1255
  year: 2016
  ident: ref141
  article-title: Analytical bias exceeding desirable quality goal in 4 out of 5 common immunoassays: results of a native single serum sample external quality assessment program for cobalamin, folate, ferritin, thyroid-stimulating hormone, and free T4 analyses
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2016.258962
SSID ssj0015547
Score 2.4353468
Snippet Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some...
SourceID proquest
pubmed
crossref
walterdegruyter
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1849
SubjectTerms biological variation
Clinical Laboratory Techniques - standards
Clinical Medicine - standards
Humans
Laboratories
Laboratories - standards
Medicine
outcome
performance specifications
Quality Control
Specifications
Title Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference
URI https://www.degruyter.com/doi/10.1515/cclm-2017-0772
https://www.ncbi.nlm.nih.gov/pubmed/29031018
https://www.proquest.com/docview/1965459776
https://www.proquest.com/docview/1951414230
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVuJxqKC8AgUtEhKHysXOrl_cStRSIYVTC71Z3odppJBUwQalP4jfyYz3YacEqXBxorW9a-_3eXdmZ2eGkNdlyMooTnmguGYBZzoKMjligeBlKrKS81Tggv7kU3Jyxj-ex-eDwa_erqWmFgfyaqNfyf-gCmWAK3rJ_gOyvlIogP-ALxwBYTjeCGMXWtaEaVC6QpHxsucKgH6UuBeo2zFuQUfLujOr46IA218B5VvTgXc4mUxn-PHbNmTPObAv0Y6da6V0qeNae8SGdjprFYaouJi2yaT2J2WzXHhLCPTaojY7DI71Engnp_6kTytgvLv98jC6qSwvGhMs4cuqvtL9pQyYHmEOMP7ydvTljAdJYlymD7QrSzu3Ljtkm8i-jpqjjVNB3EbNkHL2LWjbClOTI2g95va1udDvUETdCGoo8P4C7y_w_ltkewQ_MJ5uH354f_TZ26tAKGvT-LgXsOFBoYa360-wLv78odPcIzs_220SSn9dNqvameVbaef0Ptmxago9NJx7QAZ6vkvujB3Eu-T2xKL6kPzoaEjrBTU0pD0a0nUa0umcdvSgjh7vKKMtCeliTpGEFEhIWxJST0LakfAROTs-Oh2fBDadRyB5ktRBlUeiymBoCFUOYnMoGS-TNGIJG4W8qnIGB-imKtWqDKuEJ0oJVimVgc4Bs3DJHpOtOTDtKaGVknmstchjJXieZZkQFRO6hOrjXObRkASulwtpY91jypVZsRnXIXnjr780UV7-euWeA62wI8H3AqNycgzkmAzJK38aAEHjWznXiwavAdUkAuUlHJInBmzf1CjHAL1RNiTpNfR7bWx8HNB3cI0mf3bjF3hO7naf3h7ZqpeNfgFydS1eWlL_BnA203U
linkProvider Walter de Gruyter
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NU9QwFH-jy4zAARVFq6hxxhlPZdsmTVtvyICrspzA4dbJpzAsLbPb4qx_vS_bD1bQi156aNMmeXnp-8r7PYB3IqAijBPma2aoz6gJ_VRF1JdMJDIVjCXSOfTHR3x0wr6cxqdLuTDuWKU236f1vGoQUoe6VLVzlPVYAyiBh0pNLnGBQ-dmS6LhWXU5uQ8rqUNiGcDK7qeP-9_6WAIKzEWJFUaZz3kUttCNdz_zu2i6o2-uw8aPRQi7H9-SJDp4CKqbQ3MA5WKnruSO-nkL3vH_JvkINlpFlew2nPUY7pliE1b3uvpwm_Bg3Ibln8B1h3FrZqQqiTYWb5Orm5wE4hI63aGkxj9IzgvScl85nZMuvv-BUDLHnTcjZUFc3gtB7ZSMzyeiIF0PitzkKD6Fk4P9472R3xZ08BXjvPJtFkqbInMEGq3EKFCUCY5WMqdRwKzNKF5wujYxWgSWM661pFbrFLVO_A8LugWDoizMcyBWqyw2RmaxlixDM15KS6UR-Pk4U1nogd-tZa5atHNXdGOSO6sHqZs76uaOurmjrgfv-_ZXDc7HX1tud6yRt_t9ljtcRuag_LgHb_vHuCAu_CIKU9auDSqnIaqvgQfPGpbqu4oyB9Eaph4kt3hsqY8_Dgc1XmelZy_--c03sDo6Hh_mh5-Pvr6EtQXDoXCO-DYMqmltXqHWVcnX7bb6BWjjKaM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVipwKFAKBAoYCYmTu0nsOAm3UrqUx1YcKOIW-YkqlmS1m4CWX89482hp4QKXHBIntsfjzMvzDcAzGTIZJSmnhltGObMRzXTMqOIyVZnkPFXeoT89Fkcn_O3npD9NuOyOVRr7ZdGs6hYhdWwq3XhH2YA1gBJ4rPXsGy5w5N1saTyeG3cVNjIehdkINvZfvzz8NIQSUF6uK6xwxqkQcdQhN17-yu-S6ZK6eQO2fqwj2MPwzgmiyU1Q_RTa8ydf95pa7emfF9Ad_2uOt2CrU1PJfstXt-GKLbfh2kFfHW4bNqddUP4OfO8Rbu2S1BUx1uFtMj_LSCA-ndMfSWq9g-S0JB3vVYsV6aP7LwgjK9x3S1KVxGe9ENRNyfR0JkvS96DJWYbiDpxMDj8eHNGunAPVXIiaujxSLkPWCA3aiHGoGZcCbWTB4pA7lzO84Gxdao0MneDCGMWcMRnqnPgXluwujMqqtPeBOKPzxFqVJ0bxHI14pRxTVuLnk1znUQC0X8pCd1jnvuTGrPA2DxK38MQtPHELT9wAng_t5y3Kx19b7vacUXS7fVl4VEbugfxEAE-Hx7ggPvgiS1s1vg2qphEqr2EA91qOGrqKcw_QGmUBpBdY7FwffxwO6rveRs8f_PObT2Dzw6tJ8f7N8buHcH3NbiiZY7ELo3rR2EeoctXqcbepfgHH-ShK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Strategies+to+define+performance+specifications+in+laboratory+medicine%3A+3+years+on+from+the+Milan+Strategic+Conference&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Panteghini%2C+Mauro&rft.au=Ceriotti%2C+Ferruccio&rft.au=Jones%2C+Graham&rft.au=Oosterhuis%2C+Wytze&rft.date=2017-10-26&rft.issn=1434-6621&rft.eissn=1437-4331&rft.volume=55&rft.issue=12&rft_id=info:doi/10.1515%2Fcclm-2017-0772&rft.externalDBID=n%2Fa&rft.externalDocID=10_1515_cclm_2017_0772
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon